Insilico Medicine strengthens its middle east presence with potential blood cancer treatment, generated by AI, first of its kind in the UAE
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Oct-2026 21:16 ET (24-Oct-2026 01:16 GMT/UTC)
Insilico Medicine highlighted novel BTK degraders discovered by its UAE team as part of its growing research presence in the Middle East. First published online in the Journal of Medicinal Chemistry (a premier international journal in medicinal chemistry) on August 14, 2026, the study represents a scientific milestone for Insilico Medicine UAE and demonstrates its capabilities in targeted protein degradation.
Medical assistance can help women suffering from severe nausea and vomiting during pregnancy, but insufficient recognition of Hyperemesis gravidarum (HG) means that many are not getting the help they need to overcome this severe and debilitating form of morning sickness.
More than a third of social media posts suggested Alzheimer’s blood tests could screen healthy people without symptoms, conflicting with current recommendations. Accounts with explicit financial interests were more than three times as likely to promote testing for asymptomatic people.
Salk scientists find B cells can promote killer T cell function in a mouse model of an aggressive breast cancer, and that the antitumor benefit of CD40 agonist treatment depends on B cells. Findings help address the major gap in research around B cells that has limited their clinical application; explain why B cell responses are associated with favorable patient outcomes; and provide a foundation for testing B cell-centered immunotherapy strategies.
A new study by researchers at Baylor College of Medicine and collaborating institutions has uncovered for the first time a biological explanation for ‘pregnancy brain’ or ‘momnesia,’ or temporary forgetfulness during pregnancy.
The Mindfulness and Tai Chi for Cancer Health (MATCH) study looked at over 500 cancer survivors with varying types and stages of cancer and found that patients experienced less pain, fatigue, and sleep problems after participating in the interventions. The study, which was published in the Journal of Clinical Oncology, was a collaborative effort between researchers at the University of Calgary, University of Toronto and Mass General Brigham in Boston, Massachusetts.